These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 27048161)
1. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma. Jiménez-Fonseca P; Gómez Saez JM; Santamaria Sandi J; Capdevila J; Navarro Gonzalez E; Zafon Llopis C; Ramón Y Cajal Asensio T; Riesco-Eizaguirre G; Grande E; Galofré JC Clin Transl Oncol; 2017 Jan; 19(1):12-20. PubMed ID: 27048161 [TBL] [Abstract][Full Text] [Related]
2. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma. Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658 [TBL] [Abstract][Full Text] [Related]
3. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Bible KC; Kebebew E; Brierley J; Brito JP; Cabanillas ME; Clark TJ; Di Cristofano A; Foote R; Giordano T; Kasperbauer J; Newbold K; Nikiforov YE; Randolph G; Rosenthal MS; Sawka AM; Shah M; Shaha A; Smallridge R; Wong-Clark CK Thyroid; 2021 Mar; 31(3):337-386. PubMed ID: 33728999 [No Abstract] [Full Text] [Related]
4. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Smallridge RC; Ain KB; Asa SL; Bible KC; Brierley JD; Burman KD; Kebebew E; Lee NY; Nikiforov YE; Rosenthal MS; Shah MH; Shaha AR; Tuttle RM; Thyroid; 2012 Nov; 22(11):1104-39. PubMed ID: 23130564 [TBL] [Abstract][Full Text] [Related]
5. Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement. Hamidi S; Dadu R; Zafereo ME; Ferrarotto R; Wang JR; Maniakas A; Gunn GB; Lee A; Spiotto MT; Iyer PC; Sousa LG; Akhave NS; Ahmed S; Learned KO; Lu C; Lai SY; Williams M; Hosseini SM; Busaidy NL; Cabanillas ME JAMA Oncol; 2024 Sep; 10(9):1264-1271. PubMed ID: 38990526 [TBL] [Abstract][Full Text] [Related]
6. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Rao SN; Zafereo M; Dadu R; Busaidy NL; Hess K; Cote GJ; Williams MD; William WN; Sandulache V; Gross N; Gunn GB; Lu C; Ferrarotto R; Lai SY; Cabanillas ME Thyroid; 2017 May; 27(5):672-681. PubMed ID: 28068873 [TBL] [Abstract][Full Text] [Related]
7. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma. Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447 [TBL] [Abstract][Full Text] [Related]
8. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma. Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309 [TBL] [Abstract][Full Text] [Related]
10. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations. Smith N; Nucera C J Clin Endocrinol Metab; 2015 Jan; 100(1):35-42. PubMed ID: 25347569 [TBL] [Abstract][Full Text] [Related]
11. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012. Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388 [TBL] [Abstract][Full Text] [Related]
12. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study. Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991 [TBL] [Abstract][Full Text] [Related]
14. Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI). Galofré JC; Santamaría Sandi J; Capdevila J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Gómez Sáez JM; Jiménez-Fonseca P; Riesco Eizaguirre G; Grande E Endocrinol Nutr; 2015 Apr; 62(4):e37-46. PubMed ID: 25732322 [TBL] [Abstract][Full Text] [Related]
15. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature. Lowe NM; Loughran S; Slevin NJ; Yap BK ScientificWorldJournal; 2014; 2014():674583. PubMed ID: 25184150 [TBL] [Abstract][Full Text] [Related]
16. CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors. Min IM; Shevlin E; Vedvyas Y; Zaman M; Wyrwas B; Scognamiglio T; Moore MD; Wang W; Park S; Park S; Panjwani S; Gray KD; Tassler AB; Zarnegar R; Fahey TJ; Jin MM Clin Cancer Res; 2017 Dec; 23(24):7569-7583. PubMed ID: 29025766 [No Abstract] [Full Text] [Related]
19. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Zhou M; Chen Y; Adachi M; Wen X; Erwin B; Mawlawi O; Lai SY; Li C Biomaterials; 2015 Jul; 57():41-9. PubMed ID: 25913249 [TBL] [Abstract][Full Text] [Related]
20. Anaplastic thyroid carcinoma: a 25-year single-institution experience. Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]